These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11817320)

  • 21. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function.
    Matzkies FK; Reinecke H; Tombach B; Kosch M; Hegger K; Milius M; Hohage H; Kisters K; Kerber S; Schaefer RM
    Am J Nephrol; 2000; 20(4):300-4. PubMed ID: 10970983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dialysis adequacy today: a European perspective.
    Locatelli F; Canaud B
    Nephrol Dial Transplant; 2012 Aug; 27(8):3043-8. PubMed ID: 22743335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane innovation: closer to native kidneys.
    Storr M; Ward RA
    Nephrol Dial Transplant; 2018 Oct; 33(suppl_3):iii22-iii27. PubMed ID: 30281130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of the new, steam-sterilized polysulfone high-flux dialyzer.
    Schaefer RM; Kulzer P; Gilge U; Schaefer L; Heidland A
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S21-5. PubMed ID: 7923978
    [No Abstract]   [Full Text] [Related]  

  • 26. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration.
    Fry AC; Singh DK; Chandna SM; Farrington K
    Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of polysulfone membranes to the success of convective dialysis therapies.
    Bowry SK; Gatti E; Vienken J
    Contrib Nephrol; 2011; 173():110-118. PubMed ID: 21865783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quo vadis dialysis membrane?
    Vienken J; Bowry S
    Artif Organs; 2002 Feb; 26(2):152-9. PubMed ID: 11879244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
    Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
    Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of two different high-flux dialysis membranes on insulin resistance in non-diabetic end-stage renal disease patients.
    Kara M; Gurluler E; Cakır U
    Ren Fail; 2015; 37(8):1293-6. PubMed ID: 26399977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term experience with high-flux polysulfone in hemodialysis.
    Civati G; Teatini U; Guastoni C; Perego A; Perrino ML; Ballerini L; Minetti L
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S26-30. PubMed ID: 7923979
    [No Abstract]   [Full Text] [Related]  

  • 34. Nano-controlled membrane spinning technology: regulation of pore size, distribution and morphology of a new polysulfone dialysis membrane.
    Bowry SK
    Contrib Nephrol; 2002; (137):85-94. PubMed ID: 12101995
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of a new polysulfone membrane for hemodialysis. Reference methodology and clinical results. (Part 1: in vitro study).
    Ronco C; Brendolan A; Cappelli G; Ballestri M; Inguaggiato P; Fortunato L; Milan M; Pietribiasi G; La Greca G
    Int J Artif Organs; 1999 Sep; 22(9):604-15. PubMed ID: 10532429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polysulfone: the development of a membrane for convective therapies.
    Heilmann K; Keller T
    Contrib Nephrol; 2011; 175():15-26. PubMed ID: 22188684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
    Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I
    Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technical and clinical evaluation of a new asymmetric polysulfone membrane (Biosulfane).
    Ronco C; Brendolan A; Crepaldi C; Bettini MC; Scabardi M; Cappellari F; Tasinazzo L; Fortunato L; La Greca G
    Int J Artif Organs; 1993 Aug; 16(8):573-84. PubMed ID: 8225648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fresenius Polysulfone--membrane developments to meet clinical demands.
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S1-60. PubMed ID: 7923976
    [No Abstract]   [Full Text] [Related]  

  • 40. Homocysteine reduction rate in internal haemodiafiltration-a comparison with other mixed dialysis therapies.
    Righetti M; Ferrario GM; Serbelloni P; Milani S; Tommasi A
    Nephrol Dial Transplant; 2006 Jul; 21(7):2034-5. PubMed ID: 16524932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.